TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 36.30
-0.20 (-0.55%)
Jan 22, 2026, 11:16 AM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 965.74 million as of January 21, 2026. Its market cap has decreased by -31.52% in one year.
Market Cap
965.74M
Enterprise Value
114.86M
Revenue
324.73M
Ranking
n/a
PE Ratio
27.03
Stock Price
36.30
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 965.74M, a decrease of -54.77%. That is a compound annual growth rate of -18.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 965.74M | 2.82% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 64.74B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |